Medical Condition News

RSS

Comprehensive book on nutritional and psychological aspects of sports rehabilitation process

When David Beckham limped off the pitch, thereby ending his chances of appearing at the Football World Cup this summer, sports injuries and rehabilitation techniques were once again front and back page news stories.

2 Apr 2010

Hospira reaches legal settlement with Sanofi-Aventis over oxaliplatin injection patent litigation

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has reached a legal settlement with Sanofi-Aventis to resolve patent litigation concerning Hospira's U.S. sales of its oxaliplatin injection, a generic version of Sanofi-Aventis' oncolytic agent, Eloxatin®.

2 Apr 2010

UK researchers receive grant to study link between manmade chemicals and heart disease

The British Heart Foundation is to fund research exploring the link between Bisphenol A (BPA), a manmade chemical found in commonly used plastics, and heart disease.

2 Apr 2010

Study finds potential role of NGF in islet transplantation

Islet transplantation is a promising treatment for type 1 diabetes mellitus. The promotion of angiogenesis is an important endeavor to prevent islet graft failure. Endothelial precursor cells (EPCs), a heterogeneous group originating in the hematopoietic compartment of bone marrow, have an important role in the angiogenesis of adult tissues.

2 Apr 2010

Scientists create genetic map to identify mechanism behind heart abnormalities

Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject.

2 Apr 2010

Brain stem cells in subventricular zone characterized by transcription factor Protein Tlx

The "cradle" of new neurons in the adult brain is well known. It is what is called the subventricular zone, a tissue structure lining the lateral ventricles. This is where neural or brain stem cells reside, which are responsible for generating new neurons if needed. For many years now, the subventricular zone has been suspected to be the origin of specific malignant brain tumors called gliomas, the most deadly type of which is glioblastoma.

2 Apr 2010

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Want to find ways that may help prevent illness naturally, for a fraction of the cost of a trip to the doctor? Interested in taking control of your health with evidence-based practices that complement conventional medicine?

2 Apr 2010

Study shows drinking cherry juice can boost recovery time for Marathon runners

Runners taking part in the April 2010 London Marathon can boost their recovery time by drinking tart cherry juice before and after the race, according to a researcher at Northumbria University.

2 Apr 2010

AHR panel calls for greater research to establish connection between creative engagement and cardiac health

The Foundation for Art & Healing today releases the proceedings from its groundbreaking Arts and the Heart Roundtable (AHR), a gathering of luminaries from the medical, arts and public health sectors regarding the connection between creative engagement and cardiac health.

2 Apr 2010

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Eli Lilly and Company announced today that its chemotherapy ALIMTA® (pemetrexed for injection) received a positive "Final Appraisal Determination" from the United Kingdom's National Institute for Health and Clinical Excellence (NICE).

2 Apr 2010

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.

2 Apr 2010

MRI study reveals worry may offset negative effects of fear and depression

A new study of brain activity in depressed and anxious people indicates that some of the ill effects of depression are modified - for better or for worse - by anxiety

2 Apr 2010

Researchers identify link between genetic mutation and schizophrenia

In what may provide the most compelling evidence to date, researchers at Columbia University Medical Center have illuminated how a genetic variant may lead to schizophrenia by causing a disruption in communication between the hippocampus and prefrontal cortex regions of the brain, areas believed to be responsible for carrying out working memory.

2 Apr 2010

Mouse study indicates rapamycin drug prevents Alzheimer's disease, extends lifespan

If research results continue to be repeated and are turned into clinical trials, a drug already approved for some uses could be marshaled - sooner than we expect - to prevent Alzheimer's disease in humans and improve health to the end of life.

2 Apr 2010

Allergan, Serenity Pharmaceuticals announce global agreement for nocturia drug development

Allergan, Inc. and Serenity Pharmaceuticals, LLC today announced a global agreement for the development and commercialization of Ser-120, a Phase III investigational drug currently in clinical development for the treatment of nocturia, a common yet often under-diagnosed urological disorder in adults characterized by frequent urination at night time.

1 Apr 2010

Cipher Pharmaceuticals' enrollment milestone in CIP-ISOTRETINOIN study triggers $2.0M milestone payment

Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.

1 Apr 2010

BELLUS Health initiates Phase I clinical study for NRM8499

BELLUS Health Inc. announced today that, on March 30, 2010, the Company initiated a Phase I clinical study for NRM8499, a prodrug of tramiprosate. NRM8499 is intended for the treatment of Alzheimer's disease.

1 Apr 2010

UC Irvine Healthcare's heart failure program earns the Gold Seal of Approval

UC Irvine Healthcare's heart failure program and Stroke & Cerebrovascular Center have again earned the Gold Seal of Approval from The Joint Commission, healthcare's predominant standards-setting and accrediting body.

1 Apr 2010

Binge eating: Helping to stop binging while saving money

A new study finds that a self-guided, 12-week program helps binge eaters stop binging for up to a year and the program can also save money for those who participate. Recurrent binge eating is the most common eating disorder in the country, affecting more than three percent of the population, or nine million people, yet few treatment options are available.

1 Apr 2010

Canadians can join Canadian Cancer Society in the fight against cancer

With the support of generous corporate partners, the Canadian Cancer Society is fighting back against cancer. This April, the Society will raise funds and awareness in partnership with companies across Canada. Supporting the companies that support the Canadian Cancer Society is another way Canadians can join the fight against cancer.

1 Apr 2010

Medical Condition News

Comprehensive book on nutritional and psychological aspects of sports rehabilitation process

Hospira reaches legal settlement with Sanofi-Aventis over oxaliplatin injection patent litigation

UK researchers receive grant to study link between manmade chemicals and heart disease

Study finds potential role of NGF in islet transplantation

Scientists create genetic map to identify mechanism behind heart abnormalities

Brain stem cells in subventricular zone characterized by transcription factor Protein Tlx

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Study shows drinking cherry juice can boost recovery time for Marathon runners

AHR panel calls for greater research to establish connection between creative engagement and cardiac health

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

MRI study reveals worry may offset negative effects of fear and depression

Researchers identify link between genetic mutation and schizophrenia

Mouse study indicates rapamycin drug prevents Alzheimer's disease, extends lifespan

Allergan, Serenity Pharmaceuticals announce global agreement for nocturia drug development

Cipher Pharmaceuticals' enrollment milestone in CIP-ISOTRETINOIN study triggers $2.0M milestone payment

BELLUS Health initiates Phase I clinical study for NRM8499

UC Irvine Healthcare's heart failure program earns the Gold Seal of Approval

Binge eating: Helping to stop binging while saving money

Canadians can join Canadian Cancer Society in the fight against cancer

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News